Attention Deficit Hyperactivity Disorder (ADHD) News and Research

RSS

Attention Deficit Hyperactivity Disorder (ADHD)

Attention deficit-hyperactivity disorder (ADHD) is a neurobehavioral disorder that affects 3-5 percent of all American children. It interferes with a person's ability to stay on a task and to exercise age-appropriate inhibition (cognitive alone or both cognitive and behavioral).

Genetic risk for ADHD contributes to language, attention deficits in general population

Are deficits in attention limited to those with attention-deficit/hyperactivity disorder (ADHD) or is there a spectrum of attention function in the general population?

17 Oct 2014

ADHD increases major depression to bipolar disorder conversion

Young people with major depression have an increased risk of conversion to bipolar disorder if they have comorbid attention deficit/hyperactivity disorder, suggest findings from a longitudinal follow-up study.

15 Oct 2014

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire plc today announced that it has received further guidance from the U.S. Food and Drug Administration on the regulatory path for SHP 465 (triple-bead mixed amphetamine salts MAS), an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) in adults.

9 Oct 2014

Brain & Behavior Research Foundation to honor 8 scientists for achievements in psychiatric research

The Brain & Behavior Research Foundation will honor eight scientists with its 2014 Outstanding Achievement Prizes for work delving into psychiatric disorders that affect one in four people. The awards, which celebrate the transformative power of neuroscience and psychiatric research to improve the lives of people with mental illness, will be presented at the Foundation's National Awards Dinner at the Pierre Hotel.

30 Sep 2014

Stimulation therapy and behavioral management training for parents reduce kids’ violent behaviors

Prescribing both a stimulant and an antipsychotic drug to children with physical aggression and attention-deficit/hyperactivity disorder (ADHD), along with teaching parents to use behavior management techniques, reduces aggressive and serious behavioral problems in children, according to a study conducted by researchers in the Department of Psychiatry at Stony Brook University School of Medicine.

4 Sep 2014

Genetics may underpin psychiatric comorbidity in bipolar patients

Relatives of people with bipolar disorder are at an increased risk of developing not only bipolarity but also other psychiatric disorders, according to Swedish researchers.

20 Aug 2014

Drinking before pregnancy can increase risk of behavioural problems in toddlers

Risk drinking before pregnancy can increase the risk of the development behavioural problems in toddlers.

5 Aug 2014

Pediatrician currently utilizes Quotient ADHD test on patients

Attention Deficit Hyperactivity Disorder (ADHD) is a common childhood condition characterized by more than normal difficulty with focus, behavior control, impulsivity and hyperactivity.

26 Jul 2014

Study explores how changes in dopamine transporter function linked to brain disorders

Recent published research in the Journal of Clinical Investigation demonstrates how changes in dopamine signaling and dopamine transporter function are linked to neurological and psychiatric diseases, including early-onset Parkinsonism and attention deficit hyperactivity disorder (ADHD).

23 Jul 2014

Use ADHD questionnaire ‘with caution’ in bipolar patients

A questionnaire used to determine whether or not someone has attention-deficit hyperactivity disorder should be used with caution in patients with bipolar disorder, Swiss researchers suggest.

16 Jul 2014

Validity of DSM-5 change to age of onset criterion for diagnosis of ADHD

A recent study published in the July 2014 issue of the Journal of the American Academy of Child and Adolescent Psychiatry confirms the validity of the DSM-5 change to the age of onset criterion for diagnosis of attention-deficit/hyperactivity disorder (ADHD).

15 Jul 2014

NIH funds Phase II 90-subject pediatric clinical trial at UCLA

NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that the U.S. National Institutes of Health (NIH) has awarded UCLA a grant that funds a Phase II 90-subject pediatric clinical trial at the University of California, Los Angeles focused on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with NeuroSigma's external trigeminal nerve stimulation (eTNS) System.

10 Jul 2014

Higher risk of psychiatric disorders found in children born to women with fertility problems

Children born to women with fertility problems have a higher risk of psychiatric disorders than naturally conceived children. The increase in risk was described as "modest" by researchers from Denmark, but was found to persist throughout childhood and into young adulthood.

30 Jun 2014

Psychostimulant increases risk of cardiovascular events in children with ADHD

Psychostimulant use to treat children and adolescents with attention-deficit/hyperactivity disorder (ADHD) is increasing worldwide, and the evaluation of the cardiovascular safety of stimulant medication used in treatment has been a recent topic of concern.

28 Jun 2014

Brain iron levels offer potential biomarker in the diagnosis of ADHD

Brain iron levels offer a potential biomarker in the diagnosis of attention deficit hyperactivity disorder (ADHD) and may help physicians and parents make better informed treatment decisions, according to new research published online in the journal Radiology.

18 Jun 2014

Researchers uncover several gene networks with potentially important roles in autism

A large new analysis of DNA from thousands of patients has uncovered several underlying gene networks with potentially important roles in autism.

9 Jun 2014

Gene networks may offer attractive targets for developing new autism drugs

A large new analysis of DNA from thousands of patients has uncovered several underlying gene networks with potentially important roles in autism.

6 Jun 2014

Neuroscientists explain how miswiring in brain area can potentially contribute to ADHD

Neuroscientists at Mayo Clinic in Florida and at Aarhus University in Denmark have shed light on why neurons in the brain's reward system can be miswired, potentially contributing to disorders such as attention deficit hyperactivity disorder (ADHD).

5 Jun 2014

BabySafe Project offers 10 steps to help pregnant women limit wireless radiation exposure

An international group of doctors and scientific experts is joining with non-profit organizations today to urge pregnant women to limit their exposure to wireless radiation from cell phones and other devices by taking simple steps to protect themselves and their unborn children.

4 Jun 2014

10,000 toddlers receive medication for ADHD, shows report

"It does not surprise me that some children are being given medicine as the easy way out but that doesn't mean it's the right way to do it," says Max Wiznitzer, MD, a pediatric neurologist at University Hospitals Rainbow Babies & Children's Hospitals about the Center for Disease Control's estimate 10,000 toddlers receive medication for attention-deficit/hyperactivity disorder (ADHD).

31 May 2014